Sign In
Buy ABBV
$250.88
-6.74 (-2.61%)
At Close: Jul 31, 2026
ABN Amro Investment Solutions Buys 105,906 Shares of AbbVie Inc. $ABBV
03:53am, Wednesday, 22'nd Jul 2026
ABN Amro Investment Solutions boosted its stake in AbbVie Inc. (NYSE: ABBV) by 80.6% in the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC)
AbbVie (ABBV) Beats Stock Market Upswing: What Investors Need to Know
06:47pm, Tuesday, 21'st Jul 2026
AbbVie (ABBV) closed at $256.18 in the latest trading session, marking a +1.11% move from the prior day.
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow
06:30pm, Tuesday, 21'st Jul 2026
It looks like a great buy-and-hold option.
IXJ vs. RSPH: Which Healthcare ETF Is the Better Buy?
01:32pm, Tuesday, 21'st Jul 2026
IXJ offers a higher dividend yield and lower volatility with global exposure, while RSPH's equal-weight approach posted a stronger 1-year return.
Which Is the Better Healthcare ETF, First Trust's Biotech-Focused FBT or State Street's Broader XLV?
07:57am, Tuesday, 21'st Jul 2026
FBT delivered 52.4% returns over one year but with deeper drawdowns, while XLV's diversified approach offers lower costs and steadier performance.
Baader Bank Aktiengesellschaft Acquires 6,263 Shares of AbbVie Inc. $ABBV
05:06am, Tuesday, 21'st Jul 2026
Baader Bank Aktiengesellschaft grew its holdings in AbbVie Inc. (NYSE: ABBV) by 560.7% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchang
Andra AP fonden Has $61.73 Million Holdings in AbbVie Inc. $ABBV
03:17am, Tuesday, 21'st Jul 2026
Andra AP fonden lifted its holdings in AbbVie Inc. (NYSE: ABBV) by 44.2% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commissi
For Global Pharma Exposure Is the VanEck Pharmaceutical ETF or iShares Healthcare Fund the Better Buy in 2026?
10:44am, Monday, 20'th Jul 2026
PPH's concentrated 26-stock portfolio delivered 28% returns over one year, while its 2% dividend yield beats IXJ by 50 basis points.
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026?
10:17am, Monday, 20'th Jul 2026
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return.
Dimensional Fund Advisors LP Sells 868,264 Shares of AbbVie Inc. $ABBV
04:12am, Monday, 20'th Jul 2026
Dimensional Fund Advisors LP lowered its stake in AbbVie Inc. (NYSE: ABBV) by 10.5% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The f
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
08:45pm, Sunday, 19'th Jul 2026
AbbVie will fund this acquisition with debt, leaving its cash reserves intact. The company should maintain its dividend program as it did after previous massive acquisitions.
3 Biggest Pharma Giants: Buy, Sell or Hold?
09:30am, Sunday, 19'th Jul 2026
The three biggest US pharma names by market cap trade at very different setups right now: Johnson & Johnson (NYSE:JNJ | JNJ Price Prediction) at $247.02 screens as the most compelling on fundamentals,
AIA Group Ltd Has $16.22 Million Stock Position in AbbVie Inc. $ABBV
04:03am, Sunday, 19'th Jul 2026
AIA Group Ltd raised its position in shares of AbbVie Inc. (NYSE: ABBV) by 23.4% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commi
AbbVie Inc. $ABBV Position Increased by Allspring Global Investments Holdings LLC
03:08am, Saturday, 18'th Jul 2026
Allspring Global Investments Holdings LLC boosted its position in shares of AbbVie Inc. (NYSE: ABBV) by 0.5% during the undefined quarter, according to the company in its most recent filing with the S
Boey® is the first and only rapid-onset and short-duration botulinum neurotoxin serotype E approved in Europe that adult patients can try for the temporary improvement of glabellar lines¹ Results ma
